Researchers in a pharmaceutical lab working with automated drug discovery equipment

INVESTMENT

9 Feb 2026

Takeda Turns to AI to Reshape Early Drug Discovery

Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

Large pharmaceutical production facility with Eli Lilly branding

MARKET TRENDS

5 Feb 2026

The Great AI Land Grab in Pharma

Drugmakers race to lock in AI partners, cut risk, and secure a lead in data-driven discovery

Tempus AI branding on a smartphone, highlighting AI-driven cancer analytics

INSIGHTS

2 Feb 2026

Paige Predict Marks Tempus AI’s Next Leap in Cancer Insight

Tempus AI expands multimodal data and launches Paige Predict to refine cancer diagnostics and drug development

Google DeepMind signage displayed at a research office entrance

RESEARCH

30 Jan 2026

DeepMind’s AlphaGenome Takes Aim at DNA’s Dark Matter

New AI model improves interpretation of regulatory DNA, helping researchers test disease hypotheses earlier in drug discovery

NVIDIA and Lilly logos displayed side by side

INNOVATION

23 Jan 2026

Why Lilly and NVIDIA Are Going All In on AI Discovery

Eli Lilly and NVIDIA launch a $1B AI lab to weave artificial intelligence into the earliest stages of drug research

AstraZeneca and Modella AI logos displayed together

PARTNERSHIPS

20 Jan 2026

Big Pharma Wants Its AI In-House. AstraZeneca Leads

AstraZeneca’s Modella AI buy cements a shift toward owned AI platforms to speed drug discovery and cut research risks

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.